Загрузка...
Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients
The effect of switching from originator infliximab to biosimilar infliximab in patients with sarcoidosis is unknown. The objective of this study is to investigate the effect of switching from Remicade(®) or Inflectra(®) to Flixabi(®) in patients with severe refractory sarcoidosis. This single center...
Сохранить в:
| Опубликовано в: : | Cells |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7922542/ https://ncbi.nlm.nih.gov/pubmed/33669641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10020441 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|